Skip to content

Clinical Evaluation of the Bioli IOL Delivery System (BIOLI-D)

Clinical Evaluation of the Bioli IOL Delivery System (BIOLI-D)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05790993
Enrollment
30
Registered
2023-03-30
Start date
2022-06-20
Completion date
2022-07-20
Last updated
2023-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract Senile

Brief summary

Cataract surgery is one of the most frequent surgeries carried out in the world. After cataract extraction an intraocular lens (IOL) is implanted in order to compensate for the crystalline lens power and correct patient's vision. In order to allow cataract extraction and IOL insertion, during the surgery a small incision is performed by the surgeon. This incision is performed using surgical knives, and a smaller incisión is associated with less postoperatory inflammation, faster corneal wound healing, and faster visual recovery. Several studies reported the importance of smaller incisions to reduce the risk of surgically induced astigmatism. In order to implant the IOL through this small incision, the IOL must be preloaded in a injector that allows introducing the IOL eficiently and consistently. The manual injector BIOLI manufactured by AST Products (model D), CE approved, is designed specifically to allow the IOL insertion safely, precisely, and controllably. Among the main characteristics of this delivery system is its design to minimize the incision size widening while inserting the IOL. The present retrospective study aims to provide more information with regards to the clinical efficacy of the BIOLI-D delivery system for the implantation of the trifocal Asqelio TFLIO130C IOL in patients submitted to cataract surgery. This will be assessed by analyzing the change in incision size after IOL implantation and the incidence of adverse events during and after the procedure.

Interventions

None listed

Sponsors

AST Products, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patients 50 years or older submitted to cataract surgery and implanted with Asqelio trifocal TFLIO130C IOL using the BIOLI-D delivery system. * Patients submitted to bilateral cataract surgery. * Transparent ocular media, other than the bilateral cataract.

Exclusion criteria

* Preoperatory corneal astigmatism greater than 0.75D * Corneal surgery or trauma prior to cataract surgery Irregular cornea * Choroidal hemorrhage * Microftalmos Severe corneal dystrophy * Uncontrolled or medically controlled glaucoma * Clinically significant macular changes * Concomitant ocular disease * Not age-related cataract * Severe optic nerve atrophy * Diabetic retinopathy * Proliferative diabetic retinopathy * Amblyopia * Extremelly shallow anterior chamber * Severe chronic uveitis * Rubella * Mature/dense cataract difficulting fundas assessment preoperatively * Prior retinal detachment * Concurrent participation in another investigation with medication or clinical devices

Design outcomes

Primary

MeasureTime frameDescription
Incision size after incisionImmediately after clear incision is performedDetermined using a Capsulorhexis Incision Gauge Set, in mm.
Incision size before IOL implantationImmediately after phacoemulsification is completeDetermined using a Capsulorhexis Incision Gauge Set, in mm.
Incision size after IOL implantationImmediately after IOL implantationDetermined using a Capsulorhexis Incision Gauge Set, in mm.
Adverse eventsDuring or after the surgical procedureIncidence of adverse events related to the use of the device, coded according to the Medical Dictionary for Regulatory Activities, and analyzed per eye (ocular), and per subject (non ocular)

Secondary

MeasureTime frameDescription
Best corrected visual acuityBefore surgeryVisual acuity in LogMAR units with best correction for distance, evaluated at a distance of 4m using ETDRS optotype
Cataract gradingBefore surgeryCataract grading before surgery using the LOCS III grading system
Refractive error PreOpBefore surgeryManifest refraction before surgery in Diopters
Refractive error PostOpOne month after surgeryManifest refraction after surgery in Diopters
Intraocular Pressure (IOP)Before surgeryPreoperative intraocular pressure measured in mmHg

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026